Dicerna Pharma (DRNA) Misses Q2 EPS by 7c
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.85), $0.07 worse than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($0.85), $0.07 worse than the analyst estimate of ($0.78).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.